Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis
This study is currently recruiting participants.
Verified October 2012 by Ospedale Civico, Lugano
Sponsor:
Claudio Gobbi
Collaborator:
Bayer
Information provided by (Responsible Party):
Claudio Gobbi, Ospedale Civico, Lugano
ClinicalTrials.gov Identifier:
NCT01701856
First received: September 18, 2012
Last updated: October 4, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2014 |
| Estimated Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |